Skip to content

Abstract 14671: Multimodality Characterization of Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Vascular Disease from the PVDOMICS Study

Nov 2026 · Circulation · 0 citations

Abstract

Background: Right ventricular (RV)-pulmonary artery (PA) coupling is a central determinant of outcomes in pulmonary hypertension (PH). While noninvasive echo- and cardiac magnetic resonance (CMR)-derived surrogates are increasingly utilized, their physiologic relationships and complementary roles across pulmonary vascular disease (PVD) phenotypes remain incompletely defined. Using paired echocardiographic and CMR data from the PVDOMICS cohort, we evaluated noninvasive coupling metrics against hemodynamics and long-term outcomes. Methods: We studied 620 PVDOMICS study participants (433 PH, 187 comparators) who underwent echocardiography, right heart catheterization, and CMR. Patients were stratified by pulmonary vascular resistance (PVR): <3, ≥3 to <5, ≥5 to <7, and ≥7 Wood units (WU). Echo- and CMR derived RV-PA coupling measures (tricuspid annular plane systolic excursion [TAPSE]/PA systolic pressure [PASP], fractional area change [FAC]/PASP, tissue Doppler imaging S’ Velocity (TDI S’)/PASP, RV free wall strain [RVFWS]/PASP, RV global longitudinal strain [RVGLS]/PASP, RV stroke volume [RVSV]/RV end-systolic volume [RVESV]) were evaluated across PVR strata, and for prediction of mortality or heart/lung transplant using standardized Cox proportional hazards regression. Multivariate models were adjusted for age, sex, and PH disease duration. Results: Echo- and CMR derived RV-PA coupling indices demonstrated a stepwise decline with increasing PVR severity, indicating progressive uncoupling (all trend p<0.001). TAPSE/PASP decreased from 0.5 in PVR <3 to 0.2 in PVR ≥7, while FAC/PASP, TDI S’/PASP, RVFWS/PASP, and RVGLS/PASP displayed similar graded deterioration. CMR-derived indices paralleled these findings, with RVSV/RVESV falling from 0.5 in lower PVR groups to 0.3 in PVR ≥7. Echocardiographic RV-PA coupling indices demonstrated the most consistent prognostic performance across low- and high-PVR strata, whereas CMR-derived RVSV/RVESV exhibited superior discrimination in the intermediate PVR ≥3 to <5 group. Conclusions: Noninvasive RV-PA coupling metrics provide robust physiologic characterization of disease phenotype. Echocardiographic and CMR derived measures capture complementary aspects of RV adaptation by integrating dynamic afterload sensitive performance with structural and volumetric remodeling. These findings support incorporation of multimodality imaging to improve phenotyping and enhance long term risk stratification across the spectrum of PVD.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.